Company news
Solana Company (NASDAQ:HSDT) news
Every Solana Company press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Solana Company Reports First Quarter 2026 Financial Results
May 15, 2026
Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026
May 11, 2026
Jito Foundation and Solana Company (NASDAQ: HSDT) Announce Strategic Partnership to Expand Institutional Solana Infrastructure Across Asi...
May 6, 2026
Solana Company (NASDAQ: HSDT) Announces Registered Direct Offering of Common Stock to Global Institutional Investor
April 27, 2026
Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth
April 9, 2026
Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results
March 30, 2026
Solana Company to Release Fourth Quarter and Full Year 2025 Operating Results on March 30, 2026
March 24, 2026
Solana Company (NASDAQ: HSDT) Announces Plan for the Pacific Backbone, a High-Speed Infrastructure Buildout for Solana
February 23, 2026
Solana Company Reports Third Quarter 2025 Financial Results
November 18, 2025
Solana Company to Release Third Quarter Operating Results on November 18, 2025
November 12, 2025
Solana Company (NASDAQ: HSDT) Releases Investor Update
November 5, 2025
Solana Company Files Application to Cease to Be a Reporting Issuer in Canada
November 4, 2025
CORRECTION – Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield
October 29, 2025
Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings
October 10, 2025
Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke
September 25, 2025
Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Tre...
September 18, 2025
Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasur...
September 15, 2025
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission ...
July 21, 2025
Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements
July 9, 2025
Helius Medical Technologies Announces Reverse Stock Split
June 27, 2025
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
June 16, 2025
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
June 12, 2025
Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimu...
June 11, 2025
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
June 4, 2025
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
June 4, 2025
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting
May 20, 2025
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®...
May 12, 2025
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsi...
March 13, 2025
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulato...
March 11, 2025
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait De...
January 22, 2025
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
January 21, 2025
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gro...
January 21, 2025
Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System
December 23, 2024
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives
November 18, 2024
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (...
November 18, 2024
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 18, 2024
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimula...
October 14, 2024
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
August 16, 2024
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
August 12, 2024
Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024
August 6, 2024
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
June 17, 2024
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference
May 31, 2024
Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
May 29, 2024
Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People ...
May 23, 2024
Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General...
May 20, 2024
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
May 13, 2024
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
May 10, 2024
Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulato...
May 6, 2024
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
May 6, 2024
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
April 24, 2024